Drug intelligence / Profile preview

ginkgolide-C

Development stage
Preclinical
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Ginkgolide C is a diterpene lactone isolated from the leaves of *Ginkgo biloba*. It belongs to the class of organic compounds known as ginkgolides and bilobalides, which are characterized by a rigid hexacyclic structure. Ginkgolide C exhibits multiple biological activities including anticoagulant, neuromodulatory, antioxidative, and anti-apoptotic effects. Mechanistically, it acts as an antagonist at platelet-activating factor (PAF) receptor and inhibits Gamma-aminobutyric acid type A receptor and Glycine receptor alpha 1 subunit. It also increases levels of matrix metalloproteinase 9 (MMP9), cAMP, and cGMP; suppresses thromboxane A2 production; inhibits platelet aggregation; scavenges free radicals; and modulates inflammatory pathways such as MAPK and TLR signaling. These properties have led to research interest in its potential for neuroprotection (e.g., in Alzheimer’s disease), anti-inflammatory action, inhibition of platelet aggregation (anticoagulant effect), and antioxidative stress reduction[1][2][4][6].

Other names
GCGinkgolide C
02

Targets

GABAA (Gamma-aminobutyric acid receptor)PTAFR (Platelet-activating factor receptor)GLRA1 (Glycine receptor subunit Alpha-1)

Beyond the preview

Go deeper on ginkgolide-C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ginkgolide-C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call